ConMed Stays the Course During Transition Year
The company bounced back in 2Q21 from the pandemic low point but, as expected, its orthopedic business remains well off...
The company bounced back in 2Q21 from the pandemic low point but, as expected, its orthopedic business remains well off...
The study was conducted to test superiority of Agili-C over microfracture and debridement to treat knee joint surface lesions....
The clearance is the first in the world using Aurora's proprietary DEXA Technology for custom made implants based upon matching...
In 2Q21, the company drove incremental gains over 2019 as markets continue to recover. DJO expects to be a $1...
The study will evaluate patients treated for cervical degenerative disc disease at two contiguous levels with the M6-C disc vs....
The intra-articular single-injection viscosupplement is intended to treat knee osteoarthritis in Taiwan, through TCM Biotech International....
Vertefix HV addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty....
Although the company finished 2Q21 ahead of its 2019 performance, its knee franchise was double digits for that same comparison...
While the company's sales increased in FY 1Q21, it issued a safety warning regarding potential side effects of its new...
The merger will create a company positioned with products and specialized salesforces serving hospital, ambulatory surgical center and office care...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.